论文部分内容阅读
目的:探讨米非司酮与甲氨蝶呤联合方案在输卵管妊娠保守治疗中的临床疗效。方法:选取2010年2月~2013年5月于本院进行治疗的96例输卵管妊娠患者,分为观察组组和对照组,每组各48例,观察组患者给予米非司酮与甲氨蝶呤联合方案保守治疗,对照组患者单纯给予米非司酮进行保守治疗,对比2种患者的治疗效果。结果:观察组48例,成功43例,失败5例,成功率为89.58%;对照组患者48例,成功34例,失败14例,成功率为70.83%。观察组治疗成功率明显高于对照组,P<0.05,差异具有统计学意义。结论:米非司酮与甲氨蝶呤联合方案治疗输卵管妊娠疗效好,成功率高,是保守治疗异位妊娠的有效方法,值得临床推广。
Objective: To investigate the clinical efficacy of combination of mifepristone and methotrexate in the conservative treatment of tubal pregnancy. Methods: 96 cases of tubal pregnancy treated in our hospital from February 2010 to May 2013 were divided into observation group and control group, 48 cases in each group. The patients in observation group were given mifepristone and methamidase Conservative treatment of pterin combined with the control group of patients treated with mifepristone conservative treatment, the treatment of two kinds of patients compared. Results: In the observation group of 48 cases, 43 cases were successful and 5 cases failed. The success rate was 89.58%. In the control group, 48 cases were successful and 34 cases failed. The success rate was 70.83%. The success rate of observation group was significantly higher than the control group, P <0.05, the difference was statistically significant. Conclusion: The combined treatment of mifepristone and methotrexate has good curative effect and high success rate in the treatment of tubal pregnancy, which is an effective method for the conservative treatment of ectopic pregnancy and is worthy of clinical promotion.